Valion Bio (VBIO) Return on Equity [ROE] (2021 - 2026)
Valion Bio (VBIO) posted Return on Equity [ROE] of -128.08% for Q2 2026, up 25.42 percentage points from -153.50% a year earlier.
Powered by 
Analysis
Valion Bio (VBIO) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, Valion Bio's Return on Equity [ROE] came in at -91.85%, up 93.11 percentage points from FY2024.
- Annual Return on Equity [ROE] shows a three-year change of +27.62 percentage points (FY2022 to FY2025).
- In prior years, Valion Bio's Return on Equity [ROE] was -184.96% in FY2024 (+43.73 pp), -228.68% in FY2023 (-109.22 pp) and -119.47% in FY2022.
- Quarterly Return on Equity [ROE] has run from a low of -265.48% in Q1 2024 to a high of -57.79% in Q1 2022 over five years.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q1 2025, with a gain of 104.11 percentage points; the weakest was Q1 2023, with a drop of 168.00 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 4.97% |
| 10 | Valion Bio | 339,352.00 | -19.10 Mn | - | -128.08% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -128.08% |
| Dec 31, 2025 | -77.97% |
| Sep 30, 2025 | -174.85% |
| Jun 30, 2025 | -153.50% |
| Mar 31, 2025 | -161.37% |
| Dec 31, 2024 | -166.51% |
| Sep 30, 2024 | -182.81% |
| Jun 30, 2024 | -212.80% |
| Mar 31, 2024 | -265.48% |
| Dec 31, 2023 | -176.46% |
| Sep 30, 2023 | -185.01% |
| Jun 30, 2023 | -217.09% |
| Mar 31, 2023 | -225.78% |
| Dec 31, 2022 | -214.83% |
| Sep 30, 2022 | -145.21% |
| Jun 30, 2022 | -91.08% |
| Mar 31, 2022 | -57.79% |
| Dec 31, 2021 | -164.57% |
API Access
Valion Bio Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=VBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "VBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=VBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();